Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association

Vanessa Blumer,Manreet K Kanwar,Christopher F Barnett,Jennifer A Cowger,Abdulla A Damluji,Maryjane Farr,Sarah J Goodlin,Jason N Katz,Colleen K McIlvennan,Shashank S Sinha,Tracy Y Wang,Manreet K. Kanwar,Christopher F. Barnett,Jennifer A. Cowger,Abdulla A. Damluji,Sarah J. Goodlin,Jason N. Katz,Colleen K. McIlvennan,Shashank S. Sinha,Tracy Y. Wang,
DOI: https://doi.org/10.1161/cir.0000000000001214
IF: 37.8
2024-02-26
Circulation
Abstract:Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assessment and management of cardiogenic shock in this high-risk and growing population are lacking. Individual programs oftentimes develop upper age limits for various interventional strategies for their patients, including heart transplantation and durable left ventricular assist devices. However, age as a lone parameter should not be used to guide individual patient management decisions in cardiogenic shock. In the assessment of risk in older adults with cardiogenic shock, a comprehensive, interdisciplinary approach is central to developing best practices. In this American Heart Association scientific statement, we aim to summarize our contemporary understanding of the epidemiology, risk assessment, and in-hospital approach to management of cardiogenic shock, with a unique focus on older adults.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?